Paraganglioma

CHICAGO — In rare hereditary cancers such as paraganglioma/pheochromocytoma, where patients travel for their care, COVID caused a disruption in their screening and treatments, according to a poster presented during ASCO Annual Meeting.

People with metastatic pheochromocytomas and paragangliomas should be closely monitored and undergo routine cross-sectional imaging while also being evaluated by a multidisciplinary team, according to a guideline published in Pancreas.

Unrecognized and untreated pheochromocytoma in women before or during pregnancy was associated with a substantially higher risk for maternal or fetal complications, according to data from a retrospective study.

Long-term treatment regimens for neuroendocrine neoplasms can be safely and temporarily delayed in the setting of life-threatening COVID-19-related symptoms, which should be “urgently treated,” according to new guidance.

Endocrine Today has compiled a list of the top recent news reports focused on neuroendocrinology and adrenal medicine.

Adults with pheochromocytoma or paraganglioma are nearly five times more likely to experience a vertebral fracture, a hallmark of osteoporosis, when compared with adults with nonfunctional adrenal tumors, according to findings published in Bone.